🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
Mild cognitive decline is common in early Parkinson disease (PD) and is ass...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-05-20
Trial ID
NCT07190404
Anxiety disorders are the most common mental disorders worldwide. In Hong K...
Status
Completed
Location
The Hong Kong Polytechnic University
Start Date
2022-12-05
Trial ID
NCT05027880
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgam...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Kamalapur Field office, Lichubagan Rd
Start Date
2024-05-09
Trial ID
NCT06413121
This study aims to evaluate safety and efficacy of a combination of 4th gen...
Status
Not Yet Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2027-06-01
Trial ID
NCT04429438
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
In this study, subjects who received primary neonatal vaccination with hepa...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04
Trial ID
NCT00657657
Treatments Being Tested